A Portfolio Approach to Accelerate Therapeutic Innovation in Ovarian Cancer

SSRN Electronic Journal
doi 10.2139/ssrn.3286330
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

STAT3 Signaling in Ovarian Cancer: A Potential Therapeutic Target

Journal of Cancer
Oncology
2020English

Surgery Is Critical to a Multidisciplinary Approach to Ovarian Cancer

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2018English

Therapeutic Approach to Hormone-Refractory Prostate Cancer

Oncology & Hematology Review (US)
2007English

Targeting Midbodies in Ovarian Cancer Stem Cells as a Therapeutic Strategy

2014English

Mesothelial-To-Mesenchymal Transition as a Possible Therapeutic Target in Peritoneal Metastasis of Ovarian Cancer

Journal of Pathology
Forensic MedicinePathology
2017English

Malignant Ascites: A Source of Therapeutic Protein Against Ovarian Cancer?

Oncotarget
Oncology
2019English

A Behavioural Approach to Efficient Portfolio Formation

SSRN Electronic Journal
2002English

Folic Acid Tagged Nanoceria as a Novel Therapeutic Agent in Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target

Frontiers in Oncology
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy